MedTrace Logo

A COMPREHENSIVE BIOMARKER EVALUATION IN BILIARY TRACT CANCER

NCT07515950 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 244

Last updated 2026-04-07

No results posted yet for this study

Summary

The REVEAL-BTC Study will analyze 5 biomarkes in samples of participants who in the past 15 year have been diagnosed with any stage of biliary tract cancer. The expression levels of the biomarkers will be correlated with clinical outcomes in the participants, which will lead to better patient stratification that will help guide the use of targeted therapies in the future.

Conditions

  • Biliary Tract Cancer (BTC)

Interventions

OTHER

No intervention

Non applicable

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-31
Primary Completion
2027-05-31
Completion
2027-07-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07515950 on ClinicalTrials.gov